A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy
D'Ausilio, A., Aiello, A., Daniel, F., Graham, C., Roccia, A., & Toumi, M. (2015). A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy. Value in Health, 18(7), A424. https://doi.org/10.1016/j.jval.2015.09.574
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.